GEN Exclusives

More »

GEN News Highlights

More »
Nov 6, 2007

Neuropsychiatrie, Decouverte & Innovation Collaborates with Genizon on Schizophrenia Research

  • Genizon BioSciences and Neuropsychiatrie, Decouverte & Innovation (NDEI) will work together to enhance discoveries made by Genizon earlier this year in a genome wide association study of schizophrenia.

    Genizon's previous work identified multiple genes associated with the disease using DNA samples from patients in the Quebec Founder Population. The population which, because of its high level of genetic homogeneity, is considered among the best for disease gene discovery, according to the companies.

    Under the terms of the agreement, NDEI will be supplying a second set of samples collected from the Quebec Founder Population. Genotyping of these samples and statistical analyses of the data will be conducted at Genizon's St. Laurent, Quebec, research center.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »